Filgrastim (G-CSF) is not on the Benefit List. Is it covered by the BC Cancer Agency (BCCA)?
Filgrastim is not on the BC Cancer Agency benefit list because it is not used for the active treatment of cancer. It is used to decrease the duration of neutropenia associated with cancer chemotherapy. However, there is a unique Pharmacare-BCCA Reimbursement program. For reimbursement, the use of filgrastim must meet specific criteria set by an expert committee from Pharmacare and BCCA. These criteria are outlined on the Filgrastim (G-CSF) Usage Form. Inpatients at CON hospitals are handled differently than outpatients, as described below. In both cases the Filgrastim Usage Form must be completed by the prescribing physician.
